Diagnostic Hybrids, Inc.
Recall Z-0792-2013, part of FDA recall event 64115. See Diagnostic Hybrids's company page.
Diagnostic Hybrids Inc started this Class III device recall on Dec 31, 2012 (voluntary: firm initiated); FDA lists it as terminated, terminated Dec 5, 2013.
- Classification: Class III
- Started: Dec 31, 2012
- Status: Terminated
RhMK product fungal contamination.
- Product
- Diagnostic Hybrids, Inc., RhMK, Model #:49-0600, 49-0600A, 49-0102A, and 49-T075A. Culture media, used in the cultivation and amplification of viruses, such as respiratory viruses, enteroviruses, measles, and poliovirus from patient specimens.
- Quantity
- 13,005 units
- Lots and codes
- Model #:49-0600, Lot#, 491206T, 491216; Model #: 49-0600A, Lot#, -A-491206T, -A-491216, -A-491216B; Model #: 49-0102A, Lot#, -A-491206T, -A-491216 and Model #: 49-T075A, Lot#, -A-491206T, -A-491216.
- Distribution
- Nationwide Distribution including the states of AR, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, WA & WI.
- Recalling firm
- Diagnostic Hybrids Inc, Athens, OH, United States
- How the firm notified
- Letter
- FDA classified
- Feb 7, 2013
Newest first, one product per recall event; search them all
- MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro…Z-0417-2015 · Class II · Oct 16, 2014 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports